T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

Saved in:
Bibliographic Details
Title: T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.
Authors: Quist-Paulsen P; Department of Hematology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway. Petter.Quist-Paulsen@ntnu.no., Toft N; Department of Hematology, Herlev University Hospital, University of Copenhagen, Herlev, Denmark., Heyman M; Childhood Cancer Research Unit, Karolinska Institute, Astrid Lindgren's Childrens' Hospital, Karolinska University Hospital, Stockholm, Sweden., Abrahamsson J; Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Griškevičius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania., Hallböök H; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Jónsson ÓG; Children's Hospital, Landspitali University Hospital, Reykjavík, Iceland., Palk K; Department of Hematology, North Estonia Medical Centre, Tallinn, Estonia., Vaitkeviciene G; Centre for Pediatric Oncology and Hematology, Children's Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos, Vilnius University, Vilnius, Lithuania., Vettenranta K; Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland., Åsberg A; Department of Pediatrics, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Frandsen TL; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark., Opdahl S; Department of Public Health and Nursing, Faculty of Medicine and Health Science, NTNU, Trondheim, Norway., Marquart HV; Department of Clinical Immunology, Section 7631, University Hospital Rigshospitalet, Copenhagen, Denmark., Siitonen S; Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland., Osnes LT; Department of Immunology, Oslo University Hospital, Oslo, Norway., Hultdin M; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden., Overgaard UM; Department of Hematology, The University Hospital Rigshospitalet, Copenhagen, Denmark., Wartiovaara-Kautto U; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.; Institute Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.
Source: Leukemia [Leukemia] 2020 Feb; Vol. 34 (2), pp. 347-357. Date of Electronic Publication: 2019 Oct 14.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-019-0598-2